Clinical Trials in Georgia

Showing 2701-2720 of 12,343 trials

PTG-300 in Subjects With Hereditary Hemochromatosis

NCT04202965

This study will be conducted at multiple sites and every patient will get treated with PTG-300. The objective of the study is to assess the effect of PTG-300 in treating adult hereditary hemochromatosis patients.

Hereditary Hemochromatosis

Protagonist Therapeutics, Inc.16 participantsStarted Mar 2020

Fayetteville, Georgia, United States • Bethesda, Maryland, United States • Charlotte, North Carolina, United States +8 more locations

RECRUITINGPhase 265 miles

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.

Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction

Salubris Biotherapeutics Inc282 participantsStarted Mar 2024

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +59 more locations

PTG-300 in Subjects With Hereditary Hemochromatosis

Study of JK07 in Patients With Chronic Heart Failure

Find Trials by Condition in Georgia

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Families Left Behind

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

Sickle Cell Disease, Hemechip

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

STICH3C Cardiac Magnetic Resonance Observational Study

The ReTAVI Prospective Observational Registry